Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alberto Ardura-Fabregat, Erik Boddeke, Antonio Boza‐Serrano, et al.
CNS Drugs (2017) Vol. 31, Iss. 12, pp. 1057-1082
Open Access | Times Cited: 205

Showing 1-25 of 205 citing articles:

The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders
Anuradha Tarafdar, Giordano Pula
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3824-3824
Open Access | Times Cited: 316
Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders
Eryn L. Werry, Fiona Bright, Olivier Piguet, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3161-3161
Open Access | Times Cited: 218
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2021) Vol. 72, pp. 101496-101496
Open Access | Times Cited: 217
Blood‐based biomarkers for Alzheimer's disease
Antoine Leuzy, Niklas Mattsson, Sebastian Palmqvist, et al.
EMBO Molecular Medicine (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 214
Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?
Karan Govindpani, Laura G McNamara, Nicholas R Smith, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 5, pp. 651-651
Open Access | Times Cited: 209
The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease
Niklas Lonnemann, Shirin Hosseini, Carlo Marchetti, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 50, pp. 32145-32154
Open Access | Times Cited: 205
Neuroinflammation in Alzheimer’s Disease
Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária Čarná, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 524-524
Open Access | Times Cited: 204
APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
Md. Sahab Uddin, Md. Tanvir Kabir, Abdullah Al Mamun, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 4, pp. 2450-2465
Closed Access | Times Cited: 172
Prevention of dementia in an ageing world: Evidence and biological rationale
Giulia Grande, Chengxuan Qiu, Laura Fratiglioni
Ageing Research Reviews (2020) Vol. 64, pp. 101045-101045
Open Access | Times Cited: 170
Advances in the development of new biomarkers for Alzheimer’s disease
Timofey O. Klyucherev, Pawel K. Olszewski, Alena A. Shalimova, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 158
RNA 2′-O-Methylation (Nm) Modification in Human Diseases
Dilyana G. Dimitrova, Laure Teysset, Clément Carré
Genes (2019) Vol. 10, Iss. 2, pp. 117-117
Open Access | Times Cited: 157
Role of natural products for the treatment of Alzheimer's disease
Tayebeh Noori, Ahmad Reza Dehpour, Antoni Sureda, et al.
European Journal of Pharmacology (2021) Vol. 898, pp. 173974-173974
Closed Access | Times Cited: 117
Multimorbidity burden and dementia risk in older adults: The role of inflammation and genetics
Giulia Grande, Alessandra Marengoni, Davide Liborio Vetrano, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 5, pp. 768-776
Open Access | Times Cited: 104
CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases
Meena S. Subbarayan, Aurélie Joly‐Amado, Paula C. Bickford, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107989-107989
Closed Access | Times Cited: 104
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
Bartosz Twarowski, Mariola Herbet
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6518-6518
Open Access | Times Cited: 99
Neuroinflammation: A Potential Risk for Dementia
Md Afroz Ahmad, Ozaifa Kareem, Mohammad Khushtar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 616-616
Open Access | Times Cited: 87
Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases
Rachel J. Boyd, Dimitri Avramopoulos, Lauren L. Jantzie, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 75
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Julia Odum, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16288-16288
Open Access | Times Cited: 58
Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF
Sumonto Mitra, Homira Behbahani, Maria Eriksdotter
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 137
Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders
Vivian Hook, Michael C. Yoon, Charles Mosier, et al.
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020) Vol. 1868, Iss. 8, pp. 140428-140428
Open Access | Times Cited: 129
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Dylan J. Finneran, Kevin Nash
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 117
The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis
Nanyang Liu, Jiahui Sun, Xiyuan Wang, et al.
Journal of Alzheimer s Disease (2020) Vol. 78, Iss. 4, pp. 1775-1782
Open Access | Times Cited: 98
Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
Hongmei Li, Chia‐Chen Liu, Hui Zheng, et al.
Translational Neurodegeneration (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 90
NGF steers microglia toward a neuroprotective phenotype
Caterina Rizzi, Alexia Tiberi, Michela Giustizieri, et al.
Glia (2018) Vol. 66, Iss. 7, pp. 1395-1416
Open Access | Times Cited: 83
Treadmill Exercise Decreases Aβ Deposition and Counteracts Cognitive Decline in APP/PS1 Mice, Possibly via Hippocampal Microglia Modifications
Xianliang Zhang, Qiang He, Tao Huang, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 81
Page 1 - Next Page

Scroll to top